The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimary Health Regulatory News (PHP)

Share Price Information for Primary Health (PHP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 94.45
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.15 (0.159%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 94.45
PHP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Primary Health Properties PLC

6 Feb 2019 16:48

RNS Number : 3004P
Citadel Group
06 February 2019
 

 

 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%

OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

(a) Full name of discloser:

Citadel Group

(b) Owner or controller of interests and short positions

disclosed, if different from 1(a):

The naming of nominee or vehicle companies is

insufficient. For a trust, the trustee(s), settlor and

beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant

securities this form relates:

Use a separate form for each offeror/offeree

PRIMARY HEALTH PROPERTIES PLC

(d) If an exempt fund manager connected with an

offeror/offeree, state this and specify identity of

offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest

practicable date prior to the disclosure

05 February, 2019

(f) In addition to the company in 1(c) above, is the

discloser making disclosures in respect of any other

party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

MEDICX FUND LTD

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

Convertible Bond ISIN XS1067950615

Interests

Short Positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

4,700,000

27.65

0

0.00

(2) Cash-settled derivatives:

0

0.00

0

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

TOTAL:

4,700,000

27.65

0

0.00

Class of relevant security:

Common Stock ISIN GB00BYRJ5J14

Interests

Short Positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0.00

16,793

0.00

(2) Cash-settled derivatives:

8,299

0.00

4,642,893

0.60

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

TOTAL:

8,299

0.00

4,659,686

0.60

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

Class of relevant security

ISIN GB00BYRJ5J14

Purchase/sale

Number of securities

Price per unit

Common Stock

Purchase

11,291

1.16 GBP

Common Stock

Purchase

46,029

1.162 GBP

Common Stock

Purchase

60,546

1.164 GBP

Common Stock

Purchase

40,354

1.166 GBP

Common Stock

Sale

-43,568

1.162 GBP

Common Stock

Sale

-1,584

1.163 GBP

Common Stock

Sale

-42,615

1.164 GBP

Common Stock

Sale

-19,733

1.166 GBP

Common Stock

Sale

-1,816

1.168 GBP

Common Stock

Sale

-750

1.17 GBP

(b) Cash-settled derivative transactions

Class of relevant security

 

ISIN GB00BYRJ5J14

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Common Stock

CFD

Increasing short position

-5,256

1.162 GBP

Common Stock

CFD

Increasing short position

-5,235

1.162038 GBP

Common Stock

CFD

Increasing short position

-160,560

1.162707 GBP

Common Stock

CFD

Increasing short position

-53,520

1.162707 GBP

Common Stock

CFD

Increasing short position

-53,520

1.162707 GBP

Common Stock

CFD

Increasing short position

-4,712

1.162707 GBP

Common Stock

CFD

Reducing long position

-744

1.162037 GBP

Common Stock

CFD

Reducing long position

-543

1.162037 GBP

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

Class of relevant security

 

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Is a Supplemental Form 8 (Open Positions) attached?

NO

 Date of disclosure:

06 February, 2019

 Contact name:

Jamison Van Doesburg

 Telephone number*:

020 7645 9700

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETSSMFMMFUSELE
Date   Source Headline
11th Jan 202211:00 amRNSDirector/PDMR Shareholding
6th Jan 20227:00 amRNSDividend Declaration
17th Dec 20217:00 amRNSAcquisition
16th Dec 20219:00 amRNSDirector Declaration
15th Dec 20217:00 amRNSBoard changes
14th Dec 20213:30 pmRNSDirector/PDMR Shareholding
14th Dec 20213:30 pmRNSDirector/PDMR Shareholding
14th Dec 20217:00 amRNSAcquisition
8th Dec 20214:00 pmRNSDirector/PDMR Shareholding
8th Dec 20214:00 pmRNSDirector/PDMR Shareholding
30th Nov 20215:00 pmRNSDirector/PDMR Shareholding
30th Nov 20215:00 pmRNSDirector/PDMR Shareholding
30th Nov 202112:08 pmRNSDirector/PDMR Shareholding
26th Nov 20215:00 pmRNSTotal Voting Rights
22nd Nov 20211:00 pmRNSApplication for Listing
15th Nov 20217:00 amRNSAcquisition
11th Nov 20217:00 amRNSAcquisition
8th Nov 20214:10 pmRNSDirector/PDMR Shareholding
8th Nov 20214:10 pmRNSDirector/PDMR Shareholding
5th Nov 20215:00 pmRNSConvertible bonds: exchange price adjustment
28th Oct 20217:00 amRNSRefinancing & sustainability linked credit
25th Oct 20212:31 pmRNSHolding(s) in Company
21st Oct 202111:16 amRNSScrip Dividend Reference Price
21st Oct 20219:58 amRNSAcquisition
11th Oct 202110:57 amRNSDirector Declaration
7th Oct 202111:22 amRNSDirector/PDMR Shareholding
7th Oct 202111:00 amRNSDirector/PDMR Shareholding
7th Oct 20217:00 amRNSDividend Declaration
30th Sep 20219:18 amRNSDirector Declaration
23rd Sep 202112:32 pmRNSHolding(s) in Company
17th Sep 20217:00 amRNSLaunch of Community Impact Fund
15th Sep 20213:00 pmRNSDirector/PDMR Shareholding
15th Sep 20213:00 pmRNSDirector/PDMR Shareholding
8th Sep 20214:00 pmRNSDirector/PDMR Shareholding
8th Sep 20214:00 pmRNSDirector/PDMR Shareholding
7th Sep 20217:01 amRNSAdmission of new shares and total voting rights
7th Sep 20217:00 amRNSAcquisition
27th Aug 20217:00 amRNSAcquisition
24th Aug 202111:15 amRNSDirector/PDMR Shareholding
24th Aug 202111:15 amRNSDirector/PDMR Shareholding
20th Aug 20215:00 pmRNSTotal Voting Rights
16th Aug 20214:55 pmRNSApplication for listing
6th Aug 20219:00 amRNSDirector/PDMR Shareholding
6th Aug 20219:00 amRNSDirector/PDMR Shareholding
30th Jul 20211:00 pmRNSConvertible Bond: exchange price adjustment
28th Jul 20217:00 amRNSInterim Results
20th Jul 20217:00 amRNSInvestor Presentation
15th Jul 20214:27 pmRNSScrip dividend reference price
12th Jul 20219:28 amRNSHolding(s) in Company
7th Jul 20214:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.